Table 1 Comparison of demographic and hematological parameters between normal controls and AML patients.
Parameter | Normal controls | AML patients (pre-treatment) | p-value | ||
|---|---|---|---|---|---|
Mean ± S.D | Median IQR) | Mean ± S.D | Median (IQR) | ||
Age | 43.2 ± 7.676 | 43.5 (36.25-50) | 46.91 ± 8.768 | 48.5 (38.25–53.75) | 0.19 |
Height | 170.1 ± 8.816 | 168.8 (163–174) | 167.1 ± 21.91 | 170.2 (162.9–174) | 0.34 |
Weight | 64.92 ± 10.23 | 65.5 (55–73) | 67.54 ± 10.28 | 70 (56.25-76) | 0.18 |
BMI | 22.6 ± 3.568 | 22.0 (19.6–25) | 23.96 ± 3.405 | 24.65 (20.88-27) | 0.04 |
HB | 12.47 ± 1.6 | 12.3 (11.2–13.5) | 9.318 ± 2.685 | 9.3 (7.2–9.8) | 0.00 |
HCT | 38.31 ± 3.8 | 39.9 (35−41) | 29.4 ± 8.539 | 29 (23.4–29.9) | 0.00 |
MCV | 84.6 ± 4.8 | 85 (80–88) | 92.94 ± 5.693 | 94 (88–97) | 0.00 |
MCH | 30.95 ± 1.4 | 31 (30–32) | 29.29 ± 2.485 | 30.6 (28–31) | 0.00 |
TLC | 7.985 ± 1.8 | 7.9 (6.9–9.5) | 42.46 ± 53.28 | 17.5 (2.55–51.8) | 0.00 |
Platelets | 316.7 ± 59.8 | 327.6 (268–349) | 43.23 ± 40.14 | 32 (12-37.75) | 0.00 |
